AOSORW FOLLICULITIS AND ACNE TREATMENT CREAM- folliculitis and acne treatment cream cream

AOSORW Folliculitis and Acne Treatment Cream by

Drug Labeling and Warnings

AOSORW Folliculitis and Acne Treatment Cream by is a Otc medication manufactured, distributed, or labeled by SpineStatus LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

Salicylic Acid 1%

PURPOSE

Acne Treatment

INDICATIONS & USAGE

• For the treatment of acne
• Helps prevent newacne blemishes

WARNINGS

For external use only

lf you are under 2 years of age.

• Skin irritation and dryness are morelikely to occur when using another topical acne product at thesame time. lf irritation occurs, use only one product at a time
• Avoid eye area. In case of eye contact, flush gently and thoroughlywith water

lf swallowed, get medical helpor contact the Poison Control Center right away

DOSAGE & ADMINISTRATION

• Clean the skin thoroughly before applying this product.
• Cover the entire affected area with a thin layer one to threetimes daily.
• Because excessive drying of the skin may occur,start with one application daily, then gradually increase to two or three daily if needed or as directed by a doctor.
• lf bothersome dryness or peeling occurs, reduce application to once a day or every other day.
• Test for a New User. Apply product sparingly to one or two small affected areas during the first 3 days. lf no discomfort occurs, follow the directions stated elsewhere on this label.

OTHER SAFETY INFORMATION

Store at room temperature and out of direct sunlight. Keep the cap tightly closed after use。

INACTIVE INGREDIENT

Water, Glycerin, Cetearyl Alcohol, Propylene Glycol,Dimethicone,Sophora Flavescens Extract, Butyrospermum, Parkii (Shea) Butter, Cocos Nucifera (Coconut) Oil, Oldenlandia Diffusa Extract, PEG-100 Stearate, Dextrin, 1,2-HexanediolAloe Barbadensis Leaf Juice, Hydroxyacetophenone, CetearylGlucoside, Glyceryl Stearate, Panthenol, Triethanolamine Polyacrylate Crosspolymer-6, Carbomer, Allantoin, Niacinamide.Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer,Tocopheryl Acetate, Dipotassium Glycyrrhizate, Avena Sativa(Oat)Kernel Oil, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Azelaic Acid, Ceramide NP

QUESTIONS

Visit www.aosorw.com

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

AOSORW FOLLICULITIS AND ACNE TREATMENT CREAM 
folliculitis and acne treatment cream cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 85498-012
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ)	SALICYLIC ACID	1 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
BUTYROSPERMUM PARKII (SHEA) BUTTER (UNII: K49155WL9Y)
CETEARYL GLUCOSIDE (UNII: 09FUA47KNA)
AVENA SATIVA (OAT) KERNEL OIL (UNII: 3UVP41R77R)
GLYCERIN (UNII: PDC6A3C0OX)
ALOE BARBADENSIS LEAF JUICE (UNII: RUE8E6T4NB)
MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL (UNII: VIF565UC2G)
WATER (UNII: 059QF0KO0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
CERAMIDE NP (UNII: 4370DF050B)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
TRIETHANOLAMINE (UNII: 9O3K93S3TK)
POLYACRYLATE CROSSPOLYMER-6 (UNII: Q7UI015FF9)
DEXTRIN, CORN (UNII: VAD2K35XAJ)
NIACINAMIDE (UNII: 25X51I8RD4)
DIPOTASSIUM GLYCYRRHIZATE (UNII: CA2Y0FE3FX)
CARBOMER (UNII: 0A5MM307FC)
SOPHORA FLAVESCENS ROOT (UNII: IYR6K8KQ5K)
COCOS NUCIFERA (COCONUT) OIL (UNII: Q9L0O73W7L)
PEG-100 STEARATE (UNII: YD01N1999R)
AZELAIC ACID (UNII: F2VW3D43YT)
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)
GLYCERYL STEARATE (UNII: 230OU9XXE4)
OLDENLANDIA CAPENSIS WHOLE (UNII: Z396QHB97F)
ALLANTOIN (UNII: 344S277G0Z)
PANTHENOL (UNII: WV9CM0O67Z)
CETEARYL ALCOHOL (UNII: 2DMT128M1S)
SODIUM ACRYLATE (UNII: 7C98FKB43H)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85498-012-01	100 g in 1 JAR; Type 0: Not a Combination Product	07/30/2025

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC Monograph Drug	M006	07/30/2025

Labeler - SpineStatus LLC (126780339)

Registrant - SpineStatus LLC (126780339)